As of January 22, 2025, Ginkgo Bioworks (DNA) has a market cap of $0.74 billion USD. According to our data, Ginkgo Bioworks is ranked No.5615 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.74 B |
67.05%
|
Dec 31, 2024 | $0.44 B |
-85.47%
|
Dec 29, 2023 | $3.06 B |
0.00%
|
Dec 30, 2022 | $3.06 B |
-79.66%
|
Dec 31, 2021 | $15.02 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Codexis
CDXS
|
$0.40 B |
-0.000 M
|
USA
|
Twist Bioscience
TWST
|
$3.12 B |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Repligen
RGEN
|
$9.35 B |
0.000 M
|
USA
|
Market Cap | = | DNA Stock Price | * | DNA Shares Outstanding |
= | $12.90 | * | 45.20 M | |
= | $0.74 B |